[RESEARCH] Intermittent Fasting and Fatty Liver

Intermittent fasting or IF is very much the latest and the most popular health trend worldwide including Malaysia. IF is low calorie period lasting less than 24 hours followed by a normal feeding period, and IF may achieve a more consistent weight loss probably because of better adherence than intense caloric restriction. However, what is the impact of IF to our fatty liver?

[Q&A] COVID-19: What is a Super Spreader?

The latest Sivagangga cluster from Kedah was suspected of being caused by a super spreader strain of the COVID-19 virus that originated from Egypt and Pakistan. Health authorities believed there is a high probability that the cluster is a super spreader because of its higher transmission rate compared to previous COVID-19 clusters. We spoke to Associate Prof. Dr Chan Yoke Fun, Virologist & Senior Lecturer at the Department of Medical Microbiology, Faculty of Medicine, University of Malaya to learn more.

[OPINION] Beirut Explosion: Ammonium Nitrate is Innocent Until Proven Guilty

Ammonium nitrate (AN) has become the prime focus recently as it has been alleged to be the cause of the deadly explosion in Beirut, Lebanon. AN has also been reported to be engendering explosion in numerous cases such as in Oppau (1921), Texas (1947, 2013) and Tianjin (2015). But was AN the only culprit here?

[MEDIA RELEASE] What is Your Breast Cancer Risk Score? Genetic Tool Predicts Breast Cancer Risks in Asians

A ground-breaking genetic study in Asian women led by Malaysian scientists in collaboration with Singapore and the University of Cambridge revealed that a genetics tool developed to help European women assess breast cancer risk also works in Asian women.

[Q&A] Malaysia’s Best Science Communicator on Communicating Science

Science Media Centre Malaysia spoke to Atteleth Don, the winner of FameLab Malaysia National Final 2020 Championship recently on his win and what it takes to communicate science effectively. Don beat 11 other science communicators from across the country with his winning talk ‘Save our Homes by Saving our Mangroves.’

[MEDIA RELEASE] Impact of COVID-19 on Hepatitis Elimination

Viral hepatitis is a communicable disease that can cause serious liver damage and liver cancer. Deaths from viral hepatitis, the majority (96%) are due to hepatitis B and C, are rising worldwide compared to the downward trend for the other three most common causes of communicable diseases. However, hepatitis is preventable, treatable, and for Hepatitis C, curable with timely treatment.

[OPINION] Connecting experts in the interest of science

As the world grapples with COVID-19, healthcare professionals are working round the clock to keep COVID-19 patients alive, medical scientists are racing to develop treatments and vaccines, epidemiologists are modelling infection rates to predict how the virus will continue to spread, and science journalists are disseminating news while battling the spread of misinformation.

[RESEARCH INSIDER] Volcano monitoring: Linking volcanic processes

Research Insider this week gets up close with Stanley Yip who is in his first year pursuing a PhD in Geology at the University of Bristol, UK with his major focusing on volcanology. His goal is to understand magma properties using satellite data to measure sulfur dioxide emissions from volcanoes and volcano deformation.

[OPINION] Microplastic Pollution and Health

Microplastics, broadly defined < 5 mm, are plastic particles of different shape, size and polymer composition. Recently, there has been extensive media coverage on microplastic pollution including news release from the World Health Organization on the potential environmental health threat from microplastics. Single-use plastics and inappropriate plastic waste management are the primary reasons for pollution.

[MEDIA RELEASE] WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19

These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized COVID-19 patients when compared to standard of care. Solidarity trial investigators will interrupt the trials with immediate effect.